PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-09-14

Date Title Company
14-Sep-2021 Nocturnal Polyuria Treatment Market Industry Analysis And Growth By Top Companies 2030 MARKITWIRED
14-Sep-2021 EQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC Businesswire